Pharm of psychoses Flashcards
(48 cards)
Explain the dopamine theory of schizophrenia
Abnormality of brain function in schizophrenics is due to overactivity in brain dopaminergic pathways, especially in the mesolimbic pathway.
chlorpromazine*
typical antipsychotic, D2 block, increased EPSE
haloperidol*
typical antipsychotic D2 block, increased EPSE
clozapine*
atypical antipsychotic, reduced EPSE, poor D2 block, good 5HT2a block, hypersalivation, Agranulocytosis
risperidone
atypical antipsychotic, reduced EPSE, poor D2 block, good 5HT2a block
olanzapine
atypical antipsychotic, reduced EPSE, poor D2 block, good 5HT2a block
aripiprazole
atypical antipsychotic, reduced EPSE, poor D2 block, good 5HT2a block
Describe the relationship between receptor blocking potency-selectivity (esp. 5HT vs DA), efficacy in schizophrenia, and side effect profile for typical and atypical antipsychotic agents.
typical have more D2 block, atypical have more 5HT2a block. less EPSE in atypicals but clozapine does have a couple (agranulocytosis, hypersalivation)
Describe the catecholamine hypothesis of depression and its limitations and how it may relate to the neurodegenerative hypothesis of depression.
Initial observation: Reserpine depleted brain NE and 5HT induced depression
Additional support: Effective antidepressant drugs share property to enhance NE-5HT-(DA) availability in synapse
BUT – does not totally explain etiology of depression
Effect on amines immediate – mood elevating effect delayed 2-3 weeks
Direct evidence in support largely lacking
Dysregulation of pre-and post-synaptic control of NE-5HT neurotransmission
Synaptic changes produced by antidepressants then lead to alterations of gene expression
Time frame for these changes correlates with onset of mood changes
amitriptyline*
TCAD, blocks SERT and NET, high sedation and antimuscarinic
imipramine
TCAD, blocks SERT and NET, med. sedation and antimuscarinic
desipramine
TCAD, only blocks NET, little sedation, little antiM
fluoxetine*
SSRI, blocks SERT
paroxetine*
SSRI, blocks SERT
sertraline
SSRI, blocks SERT
bupropion*
NDRI, blocks NET and DAT
venlafaxine*
SNRI along with duloxetine blocks SERT and NET
trazodone*, S/E
blocks SERT, high sedation used as sleeping med
Drowsiness
Dizziness, nausea, agitation
“Black Box Warning” for liver failure with nefazodone
phenelzine*
(MAOI) antidepressant and anxiolytic. non-selective MAOI
electroconvulsive therapy
Most rapid and effective (70-90%) treatment for severe acute depression
Can be life-saving if patient is suicidal
Usually 6-12 treatments at a frequency of 2-3 per week
Adverse effects
Medical cardiopulmonary events, fractures, orodental injuries, headache
Cognitive acute confusion, retrograde and anterograde amnesia
lithium*
mood stabilizer, used to augment antidepressants, narrow therapeutic window Slow onset (10-21 d) – necessary to accumulate Li+ in cell
Effects greatest on cells with highest level of activity (use-dependence)
Enhance 5HT action and/or diminish NE and DA effect – most favored MOA:
Interference with PIP recycling (Gq protein: IP3 and DAG)
S/E
In thyroid anti-TSH hypothyroidism
In kidney anti-ADH polyuria-polydipsia
Competes with Na+ for reabsorption
increase dietary Na+ decreaseLi+ plasma levels
Na+ restriction increases Li+ plasma levels
valproic acid
anti convulsants
carbamazepine
Carbamazepine (Tegretol)
primarily in the treatment of epilepsy and neuropathic pain.
not effective for absence seizures or myoclonic seizures. may be used in schizophrenia along with other medications and as a second line agent in bipolar disorder.
Explain the limitations of the dopamine theory of schizophrenia
- Block of D2 receptors immediate – onset of psychoses improvement 3-6 wks
- Clozapine weak D2 blocker but extremely effective antipsychotic
- If DA system completely responsible, D2 blockers would be more effective
- Evidence exists for role of glutamate and serotonin and acetylcholine systems